Literature DB >> 8663058

Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone.

M Balbín1, C López-Otín.   

Abstract

Pepsinogen C is an aspartic proteinase mainly involved in the digestion of proteins in the stomach, which is also synthesized by certain human breast tumors. To examine the possibility that extragastric production of this proteolytic enzyme could be mediated by hormonal factors, we have analyzed pepsinogen C gene expression in human breast cancer cells subjected to different hormonal treatments. Northern blot analyses revealed the expression of pepsinogen C gene by T-47D breast cancer cells after induction with dihydrotestosterone, dexamethasone, and progesterone but not with estradiol, retinoic acid, or ethanol. Reverse transcription-polymerase chain reaction analysis in a series of breast cancer cell lines confirmed the amplification of pepsinogen C mRNA after induction with dihydrotestosterone, in those cells expressing the androgen receptor mRNA. The promoter region of the pepsinogen C gene was functionally characterized by transient expression of a vector containing the promoter region cloned in front of the chloramphenicol acetyltransferase (CAT) reporter gene. CAT activity in T-47D cells was stimulated in the presence of dihydrotestosterone, dexamethasone, and progesterone but not by estradiol. By further deletion mapping of the pepsinogen C promoter, a minimal region (AGAACTattTGTTCC) was identified as being responsible for glucocorticoid-, androgen-, and progesterone-regulated gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663058     DOI: 10.1074/jbc.271.25.15175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Authors:  Florence Gizard; Romain Robillard; Barbara Gross; Olivier Barbier; Françoise Révillion; Jean-Philippe Peyrat; Gérard Torpier; Dean W Hum; Bart Staels
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

2.  Hormone-specific regulation of the kidney androgen-regulated gene promoter in cultured mouse renal proximal-tubule cells.

Authors:  Montse Soler; Olga Tornavaca; Esther Solé; Anna Menoyo; Dianne Hardy; James F Catterall; Alain Vandewalle; Anna Meseguer
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

3.  Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.

Authors:  M J Jiménez; M Balbín; J M López; J Alvarez; T Komori; C López-Otín
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

Authors:  Ping Yin; Zhihong Lin; Scott Reierstad; Ju Wu; Hiroshi Ishikawa; Erica E Marsh; Joy Innes; Youhong Cheng; Kerry Pearson; John Sayler Coon; J Julie Kim; Debabrata Chakravarti; Serdar E Bulun
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

5.  ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors.

Authors:  Britta M Jacobsen; Purevsuren Jambal; Stephanie A Schittone; Kathryn B Horwitz
Journal:  Mol Endocrinol       Date:  2009-04-16

6.  Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.

Authors:  Gillian H Little; Sanjeev K Baniwal; Helty Adisetiyo; Susan Groshen; Nyam-Osor Chimge; Sun Young Kim; Omar Khalid; Debra Hawes; Jeremy O Jones; Jacek Pinski; Dustin E Schones; Baruch Frenkel
Journal:  Cancer Res       Date:  2014-03-19       Impact factor: 12.701

7.  Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer.

Authors:  A Scorilas; B Bharaj; M Giai; E P Diamandis
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

8.  Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.

Authors:  Y Miyasaka; N Enomoto; K Nagayama; N Izumi; F Marumo; M Watanabe; C Sato
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

Review 9.  Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaei-Tavirani; Hadi Hasanzadeh; Sara Rahmati Rad; Sona Dalilan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 10.  Pepsinogen C expression, regulation and its relationship with cancer.

Authors:  Shixuan Shen; Jingyi Jiang; Yuan Yuan
Journal:  Cancer Cell Int       Date:  2017-05-23       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.